These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 12658544)

  • 1. Intravitreal gas injection for the treatment of experimental vitreous hemorrhage in rabbits.
    Mello-Filho PA; Cardillo JA; Farah ME; Morales PH; Mitre J; Magalhães O; Paranhos A; Costa RA
    Curr Eye Res; 2002 Nov; 25(5):261-5. PubMed ID: 12658544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Experiment of vitreous liquefaction induced by C3F8.
    Wang J; Li Q
    Pak J Pharm Sci; 2017 Jan; 30(1 Suppl):281-287. PubMed ID: 28625955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Sulfur hexafluoride gas, perfluorocarbon liquid, air and balanced salt solution retinal toxicity in rabbit eyes].
    Souza EV; Aihara T; Souza NV; Coutinho Neto J
    Arq Bras Oftalmol; 2005; 68(4):511-5. PubMed ID: 16322837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of intravitreous interleukin-1 in the reabsorption of experimental vitreous hemorrhage in rabbits.
    Pastor JC; Fernandez C
    Ophthalmic Res; 1993; 25(5):302-6. PubMed ID: 8259263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of intravitreal bevacizumab in experimental posterior penetrating eye injury.
    Mehdizadeh M; Fattahi F; Eghtedari M; Nowroozzadeh MH; Toosi F
    Retina; 2011 Jan; 31(1):154-60. PubMed ID: 20838359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tolerance of intravitreous interleukin-1 beta in the treatment of experimental vitreous hemorrhage.
    Pastor JC; González O; Saavedra JA; Guerra A; Angulo S
    Ophthalmic Res; 1995; 27(1):37-41. PubMed ID: 7596558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histopathologic abnormalities in rabbit retina after intravitreous injection of expansive gases and air.
    Doi M; Ning M; Semba R; Uji Y; Refojo MF
    Retina; 2000; 20(5):506-13. PubMed ID: 11039426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Temporary vitreous gas tamponade by perfluoromethylcyclopentane.
    Hui YN; Meinert H; Arnold G; Kirchhof B; Walter P; Menz DH; Heimann K
    Graefes Arch Clin Exp Ophthalmol; 1998 Sep; 236(9):709-12. PubMed ID: 9782433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of vitreolysis and vitreous detachment with hyaluronidase and perfluoropropane gas.
    Kang SW; Hyung SM; Choi MY; Lee J
    Korean J Ophthalmol; 1995 Dec; 9(2):69-78. PubMed ID: 8818320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of experimental vitreous hemorrhage with tissue plasminogen activator.
    Min WK; Kim YB; Lee KM
    Korean J Ophthalmol; 1990 Jun; 4(1):12-5. PubMed ID: 2120486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A study of the ability of tissue plasminogen activator to diffuse into the subretinal space after intravitreal injection in rabbits.
    Kamei M; Misono K; Lewis H
    Am J Ophthalmol; 1999 Dec; 128(6):739-46. PubMed ID: 10612511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Repetitive low-dose tissue plasminogen activator for the clearance of experimental vitreous hemorrhage.
    Min WK; Kim YB; Ahn BH; Seong GH
    Korean J Ophthalmol; 1994 Dec; 8(2):45-8. PubMed ID: 7853730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of submacular hemorrhage with intravitreous tissue plasminogen activator injection and pneumatic displacement.
    Hassan AS; Johnson MW; Schneiderman TE; Regillo CD; Tornambe PE; Poliner LS; Blodi BA; Elner SG
    Ophthalmology; 1999 Oct; 106(10):1900-6; discussion 1906-7. PubMed ID: 10519583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravitreal tissue plasminogen activator treatment of experimental vitreous hemorrhage.
    Johnson RN; Olsen KR; Hernandez E
    Arch Ophthalmol; 1989 Jun; 107(6):891-4. PubMed ID: 2499298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of vitreous clearance and potential retinal toxicity of intravitreal lornoxicam (xefo).
    Diakonis VF; Tsourdou A; Tzatzarakis MN; Tsika C; Charisis S; Naoumidi I; Plainis S; Tsilimbaris MK
    J Ocul Pharmacol Ther; 2013 Sep; 29(7):627-32. PubMed ID: 23556534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravitreal long-acting gas in the prevention of early postoperative vitreous hemorrhage in diabetic vitrectomy.
    Yang CM; Yeh PT; Yang CH
    Ophthalmology; 2007 Apr; 114(4):710-5. PubMed ID: 17275908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Repetitive, low-dose tissue plasminogen activator for clearance of experimental vitreous hemorrhage.
    Zhao P; Wang W; Song H; Zhu Y
    Yan Ke Xue Bao; 1995 Mar; 11(1):29-31, 40. PubMed ID: 8575602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Experimental induction of posterior vitreous detachment in rabbits with hyaluronidase and perfluoroethane (C2F6)].
    Shen LP; Wang JY; Huang ZM
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2004 Jul; 33(4):335-9. PubMed ID: 15269986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Time course of changes in aqueous flare following intravitreous gas injection in rabbits].
    Yamamoto K
    Nippon Ganka Gakkai Zasshi; 1991 Jun; 95(6):515-21. PubMed ID: 1897451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ocular and systemic toxicity of intravitreal topotecan in rabbits for potential treatment of retinoblastoma.
    Buitrago E; Del Sole MJ; Torbidoni A; Fandino A; Asprea M; Croxatto JO; Chantada GL; Bramuglia GF; Schaiquevich P
    Exp Eye Res; 2013 Mar; 108():103-9. PubMed ID: 23333535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.